CellSource News

CellSource: [Postponed] Earnings conference for the second quarter of the October 2024 fiscal year.

Jun 14 16:30

CellSource: [Summary] Non-consolidated financial statements for the six months ending on April 30, 2024 (based on Japanese accounting standards).

Jun 13 14:00

CellSource: Anicom Animal Hospital Group launches platelet-derived growth factor therapy for dogs

Apr 15 14:00

CellSource: Cell source “Egg Freezing Security Bank” service adopted as C&R's welfare system

Apr 8 14:00

Cell Source: Adipose-Derived Stem Cell/Blood-Derived Processing Contract Service Technology Update Notice

Mar 11 14:00

Cell Source: Cell Source “Egg Freezing Security Bank” service adopted as a welfare system for LIFE CREATE

Mar 11 14:00

Cell source: Unconsolidated financial results for the three months ended January 31, 2024 (based on Japanese accounting standards)

Mar 11 14:00

Cell Source: Notice of granting share transfer reservation rights from major shareholders to the President and CEO

Mar 11 14:00

Cell Source: Cell Source “Egg Freezing Safety Bank” service is provided to ITOCHU Corporation as the first welfare program

Mar 8 14:00

Cell Source: Cell Source and Mederi sign a business alliance agreement to jointly promote egg freezing and storage contract services

Mar 5 14:00

Cell source: Cell source related to regenerative medicine, egg freezing and storage contract service “Egg Freezing Security Bank” will be offered starting today

Feb 22 14:00

CellSource: Notice regarding executive personnel affairs

Jan 25 14:00

CellSource: Independent Officer Notification Form

Dec 15, 2023 14:00

CellSource: Non-consolidated Financial Results for the Fiscal Year Ended October 31, 2023 (Under Japanese GAAP)

Dec 15, 2023 14:00

CellSource: Notice regarding the change in listing market classification to the Prime Market of the Tokyo Stock Exchange

Oct 6, 2023 08:00

CellSource: Notice regarding approval of the change of listing market classification to the Prime Market of the Tokyo Stock Exchange

Sep 19, 2023 14:30

CellSource: Decision to start egg cryopreservation contract service

Sep 13, 2023 14:00

CellSource: Non-consolidated Financial Results for the Nine Months Ended July 31, 2023 (Under Japanese GAAP)

Sep 13, 2023 14:00

CellSource: Regenerative medicine-related cell source and research pharmaceuticals sign a feasibility study agreement to create Japan's first exosomal drug

Sep 13, 2023 14:00

CellSource: Cell Source and Mochida Pharmaceutical sign a partnership agreement regarding sales support for blood-derived processing contract services

Sep 12, 2023 14:00